Advertise on podcast: The Future of HIV Care

More than half of people living with HIV in the U.S. are over the age of 50, and within a few years it will likely be more than two thirds, if we're not there already. You probably already know first-hand the challenges of adapting and evolving care to meet the needs of a patient population that is older than we envisioned back when we formed a lot of the HIV care systems we now rely on.   This month, Meredith Greene, M.D., joins us to talk about that adaptation and evolution by discussing her path to becoming a leading HIV specialist and geriatrician, her experience creating the distinguished Golden Compass clinic in San Francisco, and her efforts to apply that knowledge and experience in her current role as an associate professor of medicine at the Indiana University School of Medicine and a scientist at the Center for Aging Research.   Support the podcast by visiting the transcript, which includes a summary of key points and additional resource links: https://www.thebodypro.com/podcast/hiv/future-hiv-care-meredith-greene-aging-geriatric-clinic-sept-2026   The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; and our audio editor is Kim Buikema. Thanks this month to our contributing editor Roger Pebody for his background research and interview prep assistance.

The world's largest HIV-focused meeting took place in late July — and as ever, the science came fast and furious, to the tune of more than 2,500 presentations. When a conference is this large, distilling what's likely to have the greatest import for HIV clinicians in the U.S. is one heck of a tall order. Thankfully, our guest this month is very much up to the task: Paul Sax, M.D., a professor of medicine at Harvard Medical School, the clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital in Boston, and the editor-in-chief of Clinical Infectious Diseases.   Support the pod by reading the transcript on TheBodyPro: https://www.thebodypro.com/podcast/hiv/future-hiv-care-paul-sax-international-aids-conference-aug-2026   Read more from Dr. Sax at NEJM Voices: https://voices.nejm.org/browse/voices-series/paul-sax   Or at his personal Substack, PaulSaxMD: https://paulsaxmd.substack.com/   The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; and our audio editor is Kim Buikema. Special thanks to Alina Mogollon-Volk this month for her audio editing assistance.

Outside of pregnancy, cisgender women have long been underrepresented in HIV clinical research (and frankly, even pregnancy-related evidence gaps remain substantial). That's why we invited Aadia Rana, M.D., back to the podcast this month. She shares some of the biggest unanswered questions in women's HIV care, where current research is headed, and what clinicians can do to improve their practice today.   Please support the pod by checking out the online summary/transcript of this episode: https://www.thebodypro.com/podcast/hiv/future-hiv-care-aadia-rana-cisgender-women-july-2026   Learn more about STAR, the ongoing multistate study focused on women in the southern U.S.: https://statepi.jhsph.edu/star/   The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; and our audio editor is Kim Buikema. Special thanks to our contributing editor Roger Pebody for his background research and interview prep assistance.

We are prescribing initial ART to roughly 83% of all people living with HIV in the U.S., but only 62% are taking all of their doses — and we are only retaining 56% in care. This month, University of Alabama-Birmingham clinical professor and researcher Aadia Rana, M.D., joins the podcast to answer the question: Why is this (still) happening, and what can the clinical community realistically do about it?   Please support the pod by checking out the online summary/transcript of this episode! https://www.thebodypro.com/podcast/hiv/future-hiv-care-aadia-rana-patient-engagement-june-2026   The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; and our audio editor is Kim Buikema. Special thanks to our contributing editor Roger Pebody for his background research and interview prep assistance.

After years of relatively little movement on the HIV treatment front, we're entering a new period of activity, as fresh FDA drug approvals begin to roll in and the research pipeline grows more intriguing. Longtime clinician-researcher Joel Gallant, M.D., M.P.H., joins us to discuss the current wave of two-drug regimens; the long-acting options on the (not-too-distant) horizon; and the impact of all of this on the conversations you'll have with your patients regarding HIV treatment strategy, drug resistance, and more. Please support the pod by checking out the online summary/transcript of this episode! https://www.thebodypro.com/podcast/hiv/future-hiv-care-joel-gallant-antiretroviral-therapy-may-2026   The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; and our audio editor is Kim Buikema. Special thanks to our contributing editor Roger Pebody for his interview prep assistance this month.

Demetre Daskalakis, M.D., M.P.H., has returned to his roots: He's the new chief medical officer in town at Callen-Lorde, a widely respected, LGBTQ-centric HIV and health care institution in New York City. He joins the podcast to discuss the extent to which HIV has been a "North Star" throughout the unexpected twists and turns of his medical career, as well as the role he sees for U.S. HIV clinicians amidst so much professional and political uncertainty. ¶ Read the transcript on TheBodyPro (every click helps!): https://www.thebodypro.com/podcast/hiv/future-hiv-care-demetre-daskalakis-april-2026 ¶ The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; and our audio editor is Kim Buikema. Special thanks this month to Lauren Hunter for her assistance with pre-interview research and prep.

Newly appointed IDSA CEO (and former NIAID Director) Jeanne Marrazzo, M.D., M.P.H., joins us this month to discuss a wealth of important topics that stand at the intersection of HIV research, clinical care, and policy/politics. We touch on highlights from the recent CROI 2026 science meeting — both in terms of the research and the vibes; on how the U.S. clinical community must adjust in the wake of cuts to both funding and trust in federal health agencies; on the role of IDSA, HIVMA, and other professional organizations in filling the void; and on the new era that's emerging for clinicians who seek to support their patients and colleagues during a turbulent sociopolitical time.   Read the transcript on TheBodyPro (every click helps!):   https://www.thebodypro.com/podcast/hiv/future-hiv-care-jeanne-marrazzo-croi-march-2026   The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema.

We welcome Oni Blackstock, M.D., M.H.S., to our miniseries of interviews with people who are leading some of the big conversations we're having as a health care community during a time of great change, and great strain, in HIV care provision within the U.S. Dr. Blackstock shares what has motivated her multiple evolutions along the arc of her career from HIV/PCP physician to NYC DOH assistant commissioner to health equity consultant, and the lessons she has learned along the way.   Read the transcript on TheBodyPro (every click helps!): https://www.thebodypro.com/podcast/hiv/future-hiv-care-oni-blackstock-feb-2026    The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema. Special thanks this month to contributing science editor Roger Pebody for his help with background research and interview prep.

Regardless of your specific role in HIV care, you are almost certainly feeling the deeply challenging moment we face as science-respecting, empathetic human beings. But even as the U.S. response to HIV is persistently undermined by our own federal government, many clinical leaders are finding paths forward. This month, we speak with one of them -- longtime physician/researcher/advocate Benjamin Young, M.D., Ph.D. -- about how he contextualizes our current moment, what priorities he's pursuing now, and what advice he has for healthcare providers who are striving to serve their patients, do their jobs, and support their communities.   Support the pod by clicking/tapping over to our online transcript: https://www.thebodypro.com/podcast/hiv/future-hiv-care-benjamin-young-jan-2026    Browse This Week in HIV Research, in which Dr. Young analyzes recently published clinical science: https://www.thebodypro.com/collection/this-week-in-hiv-research    The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema.

Each year on TheBodyPro, David Alain Wohl, M.D., of the University of North Carolina summarizes and analyzes the 10 new studies and noteworthy events that he feels are most likely to have a palpable impact on the way we approach HIV prevention, treatment, and patient care in the U.S. And each year on this podcast, we welcome Dr. Wohl for a discussion about these keystone moments and their import.   Read the transcript: https://www.thebodypro.com/podcast/hiv/future-hiv-care-top-10-david-wohl-dec-2025   Peruse Dr. Wohl's picks: https://www.thebodypro.com/collection/top-10-2025-hiv-clinical-developments   This podcast is hosted and executively produced by Myles Helfand, TheBodyPro's executive editor; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema.

Whether we think about it with excitement or fear (or both), AI has become a part of our daily lives — and, increasingly, it's a force we need to consider in HIV care provision. How can we best adapt to meet the moment? This month, we talk with Sean D. Young, Ph.D., M.S., a University of California-Irvine professor whose recent commentary in The Lancet HIV explores where AI is currently being integrated with HIV-focused work, where it may be utilized in the future, and how we can ensure that our use of AI is wise, well-considered, and ethical.   Read the interview transcript: https://www.thebodypro.com/podcast/hiv/future-hiv-care-ai-artificial-intelligence-sean-young-nov-2025   Read Young's commentary: https://doi.org/10.1016/S2352-3018(25)00264-4   Learn more about Young's work at the UC Institute for Prediction Technology: https://predictiontechnology.ucla.edu/   This podcast is hosted and executively produced by Myles Helfand, TheBodyPro's executive editor; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema. Extra thanks this month to our digital content producer Jessica Ellis.

This month, we're slicing up a feast of guidance and information on HIV treatment switching in the setting of viral suppression. ART, after all, is not a "set it and forget it" proposition: Even when viral load is persistently undetectable, patients and providers alike may come to see value in changing regimens. Brian R. Wood, M.D., of the University of Washington joins us at the proverbial dinner table to discuss the pros, the cons, and what the process of switching ART entails.   To learn more about this topic -- and many others of clinical importance -- visit Wood et al's National HIV Curriculum: https://www.hiv.uw.edu/     Please support us by visiting the episode transcript on TheBodyPro, which includes links to additional resources: https://www.thebodypro.com/podcast/hiv/future-hiv-care-switching-antiretroviral-therapy-brian-wood-oct-2025   This podcast is hosted and executively produced by Myles Helfand, TheBodyPro's executive editor; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema.

This month, we're talking about an infrequently discussed, but quite powerful, implement we have in our clinical toolkit for optimizing patient outcomes: our ears. HIV/sexual health physician, researcher, and author Rageshri Dhairyawan, M.B.B.S., FRCP, joins the pod to talk about the nuances of hearing our patients — i.e., listening to them, understanding and acknowledging their concerns, and incorporating it all into HIV care provision in a way that improves their long-term health and keeps them engaged in care.   Please support us by visiting the episode transcript on TheBodyPro: https://www.thebodypro.com/podcast/hiv/future-hiv-care-listening-patients-rageshri-dhairyawan-sep-2025   Our team: This podcast is hosted by Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.

This month, we're taking stock of clinically noteworthy developments from the IAS Conference on HIV Science in July. On the docket: new (definitive?) data on the relationship between weight gain and ART; a range of studies on ART strategy, including treatment simplification, injectable ART in viremic patients, intermittent oral ART dosing, and PrEP safety in pregnancy; and a glimpse at updated WHO treatment guidelines. We also discuss the general vibe at this year's meeting — and some big news regarding Laura's professional career.   Please support us by visiting the episode transcript (which includes useful context links to relevant studies): https://www.thebodypro.com/podcast/hiv/future-hiv-care-ias-conference-highlights-aug-2025   The pod people: Our co-hosts are Laura Waters, M.D., FRCP, and Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.

This month, we're diving in deep on the U.S. approval of lenacapavir for PrEP -- both the promise it offers in expanding HIV prevention options and the current uncertainty around access, both in the U.S. and abroad. We also discuss growing concern within the HIV clinical community that our gold-standard guidelines for HIV treatment, care, and prevention may be rousted loose from their long-standing home within the Office of AIDS Research at the U.S. National Institutes of Health. And Laura Waters shares what she's most eager to learn about at IAS 2025, the global HIV science meeting that is taking place as this episode drops.   Please support our podcast by visiting the transcript, which includes links to the many references we mention in this episode: https://www.thebodypro.com/podcast/hiv/future-hiv-care-lenacapavir-prep-guidelines-july-2025   The podfolx: Our co-hosts are Laura Waters, M.D., FRCP, and Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.